Lawmakers complain about proposed limits to warning labels

01/24/2008 | Star-Ledger (Newark, N.J.), The

An FDA proposal to restrict the addition of warnings to product labels would further delay informing the public about the potential dangers of drugs or medical devices, a group of House and Senate Democrats said in a letter to Commissioner Andrew von Eschenbach. "It is apparently designed to bolster the argument by companies defending against lawsuits that the regulations precluded them from adding contraindications, warnings, precautions and adverse reactions in the absence of FDA approval," the lawmakers stated.

View Full Article in:

Star-Ledger (Newark, N.J.), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN